Results 41 to 50 of about 2,573,872 (191)

Local treatment with electrochemotherapy of superficial angiosarcomas: Efficacy and safety results from a multi-institutional retrospective study [PDF]

open access: yes, 2016
Background: Angiosarcoma is an aggressive vascular neoplasm with a high propensity for local recurrence. Electrochemotherapy is an emerging skin-directed therapy, exerting prominent cytotoxic activity, and antivascular effects.
Bonadies, CARLO ALBERTO   +12 more
core   +1 more source

Clonazepam-induced lichenoid drug eruption: a case report

open access: yesBMC Psychiatry, 2021
Background Lichenoid drug eruption is rare and can mimic idiopathic lichen planus and other dermatoses. Clonazepam, a commonly used drug for the treatment of anxiety-related disorders and seizures, is known to be an unlikely cause of cutaneous adverse ...
Hee Won Yang   +3 more
doaj   +1 more source

A case of new-onset vitiligo in a patient on tofacitinib and brief review of paradoxical presentations with other novel targeted therapies [PDF]

open access: yes, 2020
With recent advancements in the understanding of vitiligo pathogenesis, Janus kinase (JAK) inhibitors have emerged as a promising new treatment modality, but their effects remain incompletely elucidated.
Alikhan, Mujahed   +4 more
core  

Antimicrobial and anti-inflammatory activity of chitosan-alginate nanoparticles: a targeted therapy for cutaneous pathogens. [PDF]

open access: yes, 2013
Advances in nanotechnology have demonstrated potential application of nanoparticles (NPs) for effective and targeted drug delivery. Here we investigated the antimicrobial and immunological properties and the feasibility of using NPs to deliver ...
Blecher-Paz, Karin   +10 more
core   +1 more source

Human plasmacytoid dendritic cells and cutaneous melanoma [PDF]

open access: yes, 2020
The prognosis of metastatic melanoma (MM) patients has remained poor for a long time. However, the recent introduction of effective target therapies (BRAF and MEK inhibitors for BRAFV600-mutated MM) and immunotherapies (anti-CTLA-4 and anti-PD-1) has ...
Bugatti, Mattia   +4 more
core   +2 more sources

Cross-linked chitosan/lysozyme hydrogels with inherent antibacterial activity and tuneable drug release properties for cutaneous drug administration

open access: yesScience and Technology of Advanced Materials, 2023
Gels with high drug release sustainability and intrinsic antibacterial properties are of high practical potential for cutaneous drug administration, particularly for wound care and skin disease treatment.
Wing-Fu Lai   +4 more
doaj   +1 more source

Bimodal Feedback for In-car Mid-air Gesture Interaction [PDF]

open access: yes, 2017
This demonstration showcases novel multimodal feedback designs for in-car mid-air gesture interaction. It explores the potential of multimodal feedback types for mid-air gestures in cars and how these can reduce eyes-off-the-road time thus make driving ...
Brewster, Stephen A.   +2 more
core   +1 more source

On the Development of a Cutaneous Flavonoid Delivery System: Advances and Limitations

open access: yesAntioxidants, 2021
Flavonoids are one of the vital classes of natural polyphenolic compounds abundantly found in plants. Due to their wide range of therapeutic properties, which include antioxidant, anti-inflammatory, photoprotective, and depigmentation effects, flavonoids
R. Costa   +3 more
semanticscholar   +1 more source

The effect of 17β-estradiol on cutaneous wound healing in protein-malnourished ovariectomized female mouse model.

open access: yesPLoS ONE, 2014
Cutaneous wound healing is delayed by protein malnutrition (PM). On the other hand, estrogen promotes cutaneous wound healing by its anti-inflammatory and cell proliferation effects.
Kanae Mukai   +6 more
doaj   +1 more source

Review and new therapeutic alternatives for the treatment of cutaneous Leishmaniasis [PDF]

open access: yes, 2014
Podeu consultar el llibre complet a: http://hdl.handle.net/2445/63704Leishmaniasis comprises a group of diseases caused by protozoa of the genus Leishmania and has two basic clinical forms, visceral Leishmaniasis and cutaneous Leishmaniasis. The clinical
Pujol Brugués, Alba   +1 more
core  

Home - About - Disclaimer - Privacy